 | • レポートコード：MRC23Q36226 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の腫瘍アブレーション装置市場について調査・分析し、世界の腫瘍アブレーション装置市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、その他）、用途別セグメント分析（肝がん、肺がん、腎がん、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Boston Scientific、Medtronic、Johnson & Johnson、Merit Medical、Varian Medical、AngioDynamics、HealthTronics、EDAP TMS、SonaCare Medical、Misonix、CAScination AG、Biomedical Srl、Chongqing Haifu Medicalなどが含まれています。世界の腫瘍アブレーション装置市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、腫瘍アブレーション装置市場規模を推定する際に考慮しました。本レポートは、腫瘍アブレーション装置の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、腫瘍アブレーション装置に関するビジネス上の意思決定に役立てることを目的としています。 ・腫瘍アブレーション装置市場の概要 - 腫瘍アブレーション装置のタイプ別セグメント - 世界の腫瘍アブレーション装置市場規模：タイプ別分析（高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、その他） - 腫瘍アブレーション装置の用途別セグメント - 世界の腫瘍アブレーション装置市場規模：用途別分析（肝がん、肺がん、腎がん、その他） - 世界の腫瘍アブレーション装置市場規模予測（2018年-2029年） ・腫瘍アブレーション装置市場の成長トレンド - 腫瘍アブレーション装置の地域別市場規模（2018年-2029年） - 腫瘍アブレーション装置市場ダイナミクス - 腫瘍アブレーション装置の業界動向 - 腫瘍アブレーション装置市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、その他 - 世界の腫瘍アブレーション装置のタイプ別市場規模（2018年-2023年） - 世界の腫瘍アブレーション装置のタイプ別市場規模（2024年-2029年） ・用途別セグメント：肝がん、肺がん、腎がん、その他 - 世界の腫瘍アブレーション装置の用途別市場規模（2018年-2023年） - 世界の腫瘍アブレーション装置の用途別市場規模（2024年-2029年） ・腫瘍アブレーション装置の地域別市場規模 - 北米の腫瘍アブレーション装置市場規模（2018年-2029年） - アメリカの腫瘍アブレーション装置市場規模（2018年-2029年） - ヨーロッパの腫瘍アブレーション装置市場規模（2018年-2029年） - アジア太平洋の腫瘍アブレーション装置市場規模（2018年-2029年） - 中国の腫瘍アブレーション装置市場規模（2018年-2029年） - 日本の腫瘍アブレーション装置市場規模（2018年-2029年） - 韓国の腫瘍アブレーション装置市場規模（2018年-2029年） - インドの腫瘍アブレーション装置市場規模（2018年-2029年） - オーストラリアの腫瘍アブレーション装置市場規模（2018年-2029年） - 中南米の腫瘍アブレーション装置市場規模（2018年-2029年） - 中東・アフリカの腫瘍アブレーション装置市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Boston Scientific、Medtronic、Johnson & Johnson、Merit Medical、Varian Medical、AngioDynamics、HealthTronics、EDAP TMS、SonaCare Medical、Misonix、CAScination AG、Biomedical Srl、Chongqing Haifu Medical ・アナリストの観点/結論 ・調査方法とデータソース |
Tumor Ablation is a general term for destroying cancer cells. Interventional ablation is a targeted, image-guided therapy for liver, kidney and lung cancers that uses the direct application of extreme heat (radiofrequency and microwave) or cold (cryoablation) to destroy tumor cells. It is most appropriate for small kidney and liver cancers that cannot be removed surgically. In fact, radiofrequency and cryoablation of small kidney cancers have been shown to be just as effective as major surgery.
Highlights
The global Oncology Ablation Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Oncology Ablation Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oncology Ablation Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Oncology Ablation Device in Liver Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Oncology Ablation Device include Boston Scientific, Medtronic, Johnson & Johnson, Merit Medical, Varian Medical, AngioDynamics, HealthTronics, EDAP TMS and SonaCare Medical, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncology Ablation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Ablation Device.
The Oncology Ablation Device market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oncology Ablation Device market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Ablation Device companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Boston Scientific
Medtronic
Johnson & Johnson
Merit Medical
Varian Medical
AngioDynamics
HealthTronics
EDAP TMS
SonaCare Medical
Misonix
CAScination AG
Biomedical Srl
Chongqing Haifu Medical
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Other
Segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Ablation Device companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Ablation Device Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oncology Ablation Device Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Ablation Device Market Perspective (2018-2029)
2.2 Oncology Ablation Device Growth Trends by Region
2.2.1 Global Oncology Ablation Device Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oncology Ablation Device Historic Market Size by Region (2018-2023)
2.2.3 Oncology Ablation Device Forecasted Market Size by Region (2024-2029)
2.3 Oncology Ablation Device Market Dynamics
2.3.1 Oncology Ablation Device Industry Trends
2.3.2 Oncology Ablation Device Market Drivers
2.3.3 Oncology Ablation Device Market Challenges
2.3.4 Oncology Ablation Device Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Ablation Device Players by Revenue
3.1.1 Global Top Oncology Ablation Device Players by Revenue (2018-2023)
3.1.2 Global Oncology Ablation Device Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Ablation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Ablation Device Revenue
3.4 Global Oncology Ablation Device Market Concentration Ratio
3.4.1 Global Oncology Ablation Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Ablation Device Revenue in 2022
3.5 Oncology Ablation Device Key Players Head office and Area Served
3.6 Key Players Oncology Ablation Device Product Solution and Service
3.7 Date of Enter into Oncology Ablation Device Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Ablation Device Breakdown Data by Type
4.1 Global Oncology Ablation Device Historic Market Size by Type (2018-2023)
4.2 Global Oncology Ablation Device Forecasted Market Size by Type (2024-2029)
5 Oncology Ablation Device Breakdown Data by Application
5.1 Global Oncology Ablation Device Historic Market Size by Application (2018-2023)
5.2 Global Oncology Ablation Device Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oncology Ablation Device Market Size (2018-2029)
6.2 North America Oncology Ablation Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oncology Ablation Device Market Size by Country (2018-2023)
6.4 North America Oncology Ablation Device Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Ablation Device Market Size (2018-2029)
7.2 Europe Oncology Ablation Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oncology Ablation Device Market Size by Country (2018-2023)
7.4 Europe Oncology Ablation Device Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Ablation Device Market Size (2018-2029)
8.2 Asia-Pacific Oncology Ablation Device Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oncology Ablation Device Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Ablation Device Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Ablation Device Market Size (2018-2029)
9.2 Latin America Oncology Ablation Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oncology Ablation Device Market Size by Country (2018-2023)
9.4 Latin America Oncology Ablation Device Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Ablation Device Market Size (2018-2029)
10.2 Middle East & Africa Oncology Ablation Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oncology Ablation Device Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Ablation Device Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Detail
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Oncology Ablation Device Introduction
11.1.4 Boston Scientific Revenue in Oncology Ablation Device Business (2018-2023)
11.1.5 Boston Scientific Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Detail
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Oncology Ablation Device Introduction
11.2.4 Medtronic Revenue in Oncology Ablation Device Business (2018-2023)
11.2.5 Medtronic Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Oncology Ablation Device Introduction
11.3.4 Johnson & Johnson Revenue in Oncology Ablation Device Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Merit Medical
11.4.1 Merit Medical Company Detail
11.4.2 Merit Medical Business Overview
11.4.3 Merit Medical Oncology Ablation Device Introduction
11.4.4 Merit Medical Revenue in Oncology Ablation Device Business (2018-2023)
11.4.5 Merit Medical Recent Development
11.5 Varian Medical
11.5.1 Varian Medical Company Detail
11.5.2 Varian Medical Business Overview
11.5.3 Varian Medical Oncology Ablation Device Introduction
11.5.4 Varian Medical Revenue in Oncology Ablation Device Business (2018-2023)
11.5.5 Varian Medical Recent Development
11.6 AngioDynamics
11.6.1 AngioDynamics Company Detail
11.6.2 AngioDynamics Business Overview
11.6.3 AngioDynamics Oncology Ablation Device Introduction
11.6.4 AngioDynamics Revenue in Oncology Ablation Device Business (2018-2023)
11.6.5 AngioDynamics Recent Development
11.7 HealthTronics
11.7.1 HealthTronics Company Detail
11.7.2 HealthTronics Business Overview
11.7.3 HealthTronics Oncology Ablation Device Introduction
11.7.4 HealthTronics Revenue in Oncology Ablation Device Business (2018-2023)
11.7.5 HealthTronics Recent Development
11.8 EDAP TMS
11.8.1 EDAP TMS Company Detail
11.8.2 EDAP TMS Business Overview
11.8.3 EDAP TMS Oncology Ablation Device Introduction
11.8.4 EDAP TMS Revenue in Oncology Ablation Device Business (2018-2023)
11.8.5 EDAP TMS Recent Development
11.9 SonaCare Medical
11.9.1 SonaCare Medical Company Detail
11.9.2 SonaCare Medical Business Overview
11.9.3 SonaCare Medical Oncology Ablation Device Introduction
11.9.4 SonaCare Medical Revenue in Oncology Ablation Device Business (2018-2023)
11.9.5 SonaCare Medical Recent Development
11.10 Misonix
11.10.1 Misonix Company Detail
11.10.2 Misonix Business Overview
11.10.3 Misonix Oncology Ablation Device Introduction
11.10.4 Misonix Revenue in Oncology Ablation Device Business (2018-2023)
11.10.5 Misonix Recent Development
11.11 CAScination AG
11.11.1 CAScination AG Company Detail
11.11.2 CAScination AG Business Overview
11.11.3 CAScination AG Oncology Ablation Device Introduction
11.11.4 CAScination AG Revenue in Oncology Ablation Device Business (2018-2023)
11.11.5 CAScination AG Recent Development
11.12 Biomedical Srl
11.12.1 Biomedical Srl Company Detail
11.12.2 Biomedical Srl Business Overview
11.12.3 Biomedical Srl Oncology Ablation Device Introduction
11.12.4 Biomedical Srl Revenue in Oncology Ablation Device Business (2018-2023)
11.12.5 Biomedical Srl Recent Development
11.13 Chongqing Haifu Medical
11.13.1 Chongqing Haifu Medical Company Detail
11.13.2 Chongqing Haifu Medical Business Overview
11.13.3 Chongqing Haifu Medical Oncology Ablation Device Introduction
11.13.4 Chongqing Haifu Medical Revenue in Oncology Ablation Device Business (2018-2023)
11.13.5 Chongqing Haifu Medical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details